Cybin (CYBN) News Today → My biggest AI fear (Do this before June 25th) (From Paradigm Press) (Ad) Free CYBN Stock Alerts $0.37 +0.02 (+5.76%) (As of 05/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLSD, Ecstasy, magic mushrooms coming to a clinic near you? Legalization nears for psychedelicstheglobeandmail.com - April 5 at 4:12 PMInside George Soros’ Portfolio: His Top 8 Stock Picksmsn.com - April 1 at 1:21 PM10 Best Stocks To Buy Under $1msn.com - April 1 at 8:21 AMFan invades the pitch smoking marijuana and sniffing glue in Brazilmsn.com - March 31 at 7:12 AMPsychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And Moremsn.com - March 30 at 10:47 AMPsyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And Moremsn.com - March 20 at 5:32 PMCybin initiates Phase 2 study for psychedelic drug DMTmsn.com - March 15 at 11:45 AMFDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placementmsn.com - March 13 at 1:47 PMCybin spikes after FDA breakthrough tag for psychedelic therapymsn.com - March 13 at 8:47 AMAnnounces Oversubscribed Private Placement of U.S. $150 Millionfinance.yahoo.com - March 13 at 8:47 AMFY2024 EPS Estimates for Cybin Inc. Lowered by Cantor Fitzgerald (NYSEAMERICAN:CYBN)marketbeat.com - March 1 at 8:28 AMCybin to Present at the TD Cowen 44th Annual Health Care Conferencefinance.yahoo.com - February 27 at 8:03 AMCybin Stock (AMEX:CYBN) Earnings Dates and Earning Callsbenzinga.com - February 22 at 2:06 PMALPN Mar 2024 25.000 callfinance.yahoo.com - February 17 at 8:29 AMCybin Inc. Q3 Earnings: Clinical Advances Amid Financial Lossbenzinga.com - February 16 at 3:25 PMCybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Resultsmsn.com - January 9 at 6:22 PMCybin Highlights Recent Topline Results and Outlines Key Upcoming Milestones Across its Clinical Development Programsfinance.yahoo.com - January 4 at 7:51 AMCybin Announces Four Poster Presentations at the 2023 American College of Neuropsychopharmacology Annual Meeting Including CYB003 Phase 2 Topline Resultsfinance.yahoo.com - December 5 at 9:45 AMCybin to Release Phase 2 Topline Safety and Efficacy Data for CYB003 in Major Depressive Disorder and Host R&D Briefing on November 30, 2023finance.yahoo.com - November 16 at 9:33 AMCybin Announces Poster Presentation at Neuroscience 2023 Annual Meetingfinance.yahoo.com - November 15 at 8:49 AMThinking about buying stock in Hanryu Holdings, Absci Corp, Spero Therapeutics, BioXcel Therapeutics, or Cybin?benzinga.com - November 14 at 10:30 AMCybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003 in Major Depressive Disorder Meeting Primary Efficacy Endpoint with Rapid and Significant Improvements in Depression Symptoms After Single Dosefinance.yahoo.com - October 31 at 11:46 AMCybin Announces Unprecedented Positive Interim Phase 2 Data for CYB003 in Major Depressive Disorder Meeting Primary Efficacy Endpoint with Rapid and Significant Improvements in Depression Symptoms After Single Dose - Full Topline Data on Track for Q4 2023finance.yahoo.com - October 31 at 11:46 AMCybin Announces Grant of Two New United States Patents Protecting its Deuterated DMT Programfinance.yahoo.com - October 25 at 8:11 AMPsychedelic drug developer Cybin completes acquisition of Small Pharmamsn.com - October 23 at 6:24 PMCybin Completes Acquisition of Small Pharma Inc. to Create International Clinical-stage Leader in Novel Psychedelic Therapeuticsfinance.yahoo.com - October 23 at 7:47 AMCybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Datesbenzinga.com - October 13 at 3:34 PMSteve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Sharesbenzinga.com - October 3 at 12:32 PMCybin Completes Enrollment in Phase 2 Study of CYB003 in Major Depressive Disorderfinance.yahoo.com - September 21 at 8:09 AMPsilocybin in depression: Study shows lasting benefitmsn.com - August 31 at 5:11 PMCanadian Investment Regulatory Organization Trade Resumption - CYBNfinance.yahoo.com - August 28 at 2:31 PMCanadian Investment Regulatory Organization Trading Halt - CYBNfinance.yahoo.com - August 28 at 9:31 AM Get Cybin News Delivered to You Automatically Sign up to receive the latest news and ratings for CYBN and its competitors with MarketBeat's FREE daily newsletter. Email Address Oil Surge Predicted... But Are You Ready (Ad)Do you own oil and gas stocks? Or are you thinking about buying some? If so, you need to see this. All the details are right here: CYBN Media Mentions By Week CYBN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYBN News Sentiment▼0.000.40▲Average Medical News Sentiment CYBN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYBN Articles This Week▼01▲CYBN Articles Average Week Get Cybin News Delivered to You Automatically Sign up to receive the latest news and ratings for CYBN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IMAB News Today CYDY News Today ELTP News Today IXHL News Today CRVO News Today ACET News Today GOSS News Today NWPHF News Today SYRS News Today ZOM News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:CYBN) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersNo experience to confident trader, meet my student…Wealth Builders InstituteBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingRevealed: The Unknown Biotech Powering AI in HealthcareBehind the MarketsThe only accurate crypto trading system I know …Weiss RatingsOil Surge Predicted... But Are You ReadyThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cybin Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
